Home Healthcare

Healthcare

Noxopharm Announces Conclusion of DARRT-1 Phase 1b Study in Late-Stage Prostate Cancer with Positive...

Australian drug development company, Noxopharm Limited (ASX: NOX) recently announced the completion of DARRT-1 Phase 1b study in late-stage prostate cancer, reporting  positive end-of-study data. Following that...
ASX Health care Stocks to look at

Integration of Health Care with Technology, Looking through 2020s

Technology certainly plays a significant role in each segment of the industry, more so than ever, and health care sector is no different. Introduction...
Healthcare Buzz: ResApp Health, Sigma Healthcare, EBOS Group

Healthcare Buzz: ResApp Health, Sigma Healthcare, EBOS Group

Australian healthcare system is vast, and it has many healthcare service providers with their roots in drug development, imaging solutions, pathology, medical devices, distribution,...

Noxopharm Eyeing to Revolutionise Cancer Therapy; Focusing on Turning Veyonda® into Reality

Australia headquartered clinical stage drug development company, Noxopharm Limited (ASX: NOX) has been in the spotlight for its potentially transformative therapy in late-stage prostate...

Prescient Unveils Encouraging Results: Eradication of Cancer in Three Acute Myeloid Leukemia Patients

Clinical-stage Oncology Company, Prescient Therapeutics Limited (ASX: PTX), that develops personalised medicine approaches to address mutations causing cancer. Prescient’s deep product pipeline include 2...

Centralising Attention on BPH Energy’s Key Growth Drivers

Diversified player, BPH Energy Limited (ASX: BPH) holds a significant stake in oil and gas exploration company, Advent Energy Ltd that has an attractive...

A Walk-Through Prescient’s 2019 Achievements

Prescient Therapeutics Limited (ASX: PTX) is involved in the development of breakthrough personalised cancer therapies via its novel anti-cancer drug candidates, PTX-100 and PTX-200, that...

Imugene Announces Completion of Clinical Grade GMP Batches by CF33 Oncolytic Virus Constructs

In a recent ASX update, Australian headquartered Imugene Limited (ASX: IMU) has notified that CF33 oncolytic virus CheckVacc and Vaxinia constructs have completed clinical...
Health Care Stocks In Red Zone Today: Mayne, PolyNovo, Nanosonics

Health Care Stocks In Red Zone Today: Mayne, PolyNovo, Nanosonics

Health care sector is one of the most significant contributors to the Australian economy, known for delivering best services by advancing technology. Health care sector...
Latest Developments Paving Next Leg of Growth for 6 Health Care Stocks

Latest Developments Paving Next Leg of Growth for 6 Health Care Stocks

On 22 November 2019, S&P/ASX 200 ended the session in green, as the index witnessed a rise of 36.9 points or 0.55% on an...

Recent News